OptraSCAN® Launches BactoSiA™, Bringing AI-Enabled Standardization to TB Smear Microscopy

Aiforia has entered into an exclusive licensing agreement with the Mayo Clinic in the United States to globally commercialize an AI model that improves prediction of colorectal cancer recurrence. Aiforia Technologies Plc - January 2, 2024 at...

Based in Liège, Belgium, Cytomine Corporation SA develops a range of solutions in the field of Digital Pathology including automated analysis of biomedical images using AI. Our software is used as a virtual microscope in teaching and complex...

WED, DEC 27, 2023 12:00 CET - The Provincial Health Authority of Catania in Italy has selected Aiforia Technologies Plc as a partner for AI-assisted diagnostics in the anatomic pathology laboratory of Gravina Hospital. The collaboration...

Gestalt: This award is another validation of our contributions to supporting better healthcare through technology. SPOKANE, Wash., Dec. 21, 2023 /PRNewswire/ -- Gestalt has been named the Most Innovative Company, 2023 by LaunchPad Inland...

Epredia and Aiforia Partnership Will Pave the Way for New RegenMed Clinical Trials Catalyst Program WINSTON-SALEM, N.C.--(BUSINESS WIRE)--PHC Group, a global healthcare company and leader in diagnostics and life sciences, will expand its...

South Korean biotech company GC Cell Corp. said Thursday that it signed a joint research and supply agreement with medical artificial intelligence (AI) company Lunit Inc. for new drug candidate AB-201. Under the agreement, GC Cell will conduct...